102 related articles for article (PubMed ID: 20599939)
21. Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation.
Pandey M; Prakash O; Santhi WS; Soumithran CS; Pillai RM
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):379-83. PubMed ID: 18356024
[TBL] [Abstract][Full Text] [Related]
22. Loss of p53 gene as a biomarker of high risk oral leukoplakias.
Saranath D; Tandle AT; Deo MG; Mehta AR; Sanghvi V
Indian J Biochem Biophys; 1997 Jun; 34(3):266-73. PubMed ID: 9425746
[TBL] [Abstract][Full Text] [Related]
23. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity.
Werkmeister R; Brandt B; Joos U
Br J Oral Maxillofac Surg; 1999 Dec; 37(6):477-80. PubMed ID: 10687911
[TBL] [Abstract][Full Text] [Related]
24. Proteic expression of p53 and cellular proliferation in oral leukoplakias.
Santos-García A; Abad-Hernández MM; Fonseca-Sánchez E; Cruz-Hernández JJ; Bullón-Sopelana A
Med Oral Patol Oral Cir Bucal; 2005; 10(1):5-8; 1-5. PubMed ID: 15627901
[TBL] [Abstract][Full Text] [Related]
25. Proliferative verrucous leukoplakia of the gingiva.
Fettig A; Pogrel MA; Silverman S; Bramanti TE; Da Costa M; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):723-30. PubMed ID: 11113818
[TBL] [Abstract][Full Text] [Related]
26. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia.
Zhang S; Li Y; Li L; Zhang Y; Gao N; Zhang Z; Zhao H
J Oral Maxillofac Surg; 2009 May; 67(5):1074-82. PubMed ID: 19375021
[TBL] [Abstract][Full Text] [Related]
28. Detection of survivin mRNA in healthy oral mucosa, oral leucoplakia and oral cancer.
Lodi G; Franchini R; Bez C; Sardella A; Moneghini L; Pellegrini C; Bosari S; Manfredi M; Vescovi P; Carrassi A
Oral Dis; 2010 Jan; 16(1):61-7. PubMed ID: 19732355
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome.
Atula T; Hedström J; Ristimäki A; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
Oncol Rep; 2006 Sep; 16(3):485-90. PubMed ID: 16865247
[TBL] [Abstract][Full Text] [Related]
31. [The correlation analysis between frequency of micronucleated cells of exfoliated oral mucosa cells and oral mucosa cells in different grading of oral leukoplakia lesions].
Sun Z; Li N; Zhang Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 Nov; 35(6):439-41. PubMed ID: 11780528
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid.
Beenken SW; Sellers MT; Huang P; Peters G; Krontiras H; Dixon P; Stockard C; Listinsky C; Grizzle WE
Head Neck; 1999 Sep; 21(6):566-73. PubMed ID: 10449674
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
35. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
36. 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion.
Ma N; Tagawa T; Hiraku Y; Murata M; Ding X; Kawanishi S
Nitric Oxide; 2006 Mar; 14(2):137-43. PubMed ID: 16290060
[TBL] [Abstract][Full Text] [Related]
37. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
[TBL] [Abstract][Full Text] [Related]
38. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa.
Ogden GR; Kiddie RA; Lunny DP; Lane DP
J Pathol; 1992 Apr; 166(4):389-94. PubMed ID: 1381431
[TBL] [Abstract][Full Text] [Related]
39. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
40. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
